Non-Profit R&D Model Shows Success In Bringing To Market New Treatments For Neglected Diseases, DNDi Report Says
Health Policy Watch: Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market
“A ‘public interest R&D’ model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday…” (Ren, 10/30).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.